#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11702	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2027	572.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1689	1689	T	654	T,C	605,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11702	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2027	572.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1423	1423	C	768	C	712	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22302	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3739	595.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1844	1844	A	744	A	688	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22302	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3739	595.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2478	2478	C	733	C	676	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22302	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3739	595.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2552	2552	A	714	A	668	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22302	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3739	595.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3104	3104	C	679	C	637	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	57618	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1509	3803.5	0	.	p	.	0	P12S	NONSYN	34	36	CCC	349	351	TCC	4754;4762;4792	T,C;C,T,A;C,A,T	4459,1;4431,4,1;4462,1,1	.	Betalactam resistance
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	G5V	NONSYN	13	15	GGT	454	456	GTT	110;110;110	G;T;T	104;105;103	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	E12K	NONSYN	34	36	GAA	475	477	AAA	119;122;127	A;A;A	108;108;114	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	F31L	NONSYN	91	93	TTT	532	534	TTG	132;132;132	T;T;G	123;125;125	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	565	567	CAA	162;161;162	C;A;A	154;155;155	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	S75P	NONSYN	223	225	TCC	664	666	CCT	161;162;163	C;C;T	143;144;145	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	V87A	NONSYN	259	261	GTA	700	702	GCA	136;136;137	G;C;A	126;127;127	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	V130L	NONSYN	388	390	GTC	829	831	CTC	156;155;157	C,A;T;C	139,1;133;138	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	R135C	NONSYN	403	405	CGC	844	846	TGT	153;150;148	T;G;T	135;133;133	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	T137A	NONSYN	409	411	ACG	850	852	GCG	149;145;146	G;C;G	139;132;137	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	E151K	NONSYN	451	453	GAA	892	894	AAG	174;175;175	A;A;G,A	161;162;162,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	T152N	NONSYN	454	456	ACC	895	897	AAT	175;174;174	A;A,C;T,C	162;163,1;162,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1093	1095	TTG	106;102;101	T;T;G	102;99;98	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1123	1125	AGC	98;98;97	A;G;C	96;96;94	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1192	1194	CTG	89;88;87	C;T;G	86;81;83	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1198	1200	TCC	88;88;89	T;C;C	86;83;86	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1213	1215	GTG	104;104;105	G;T;G,A	94;90;96,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1360	folP	852	852	93.78	folP.l6.c30.ctg.1	1615	83.7	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1264	1266	GCG	129;129;128	G;C;G	122;120;121	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4608	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3370	136.4	1	SNP	p	S91F	0	.	.	271	273	TCC	557	559	TCC	174;175;175	T;C;C	162;161;163	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4608	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3370	136.4	1	SNP	p	D95G	0	.	.	283	285	GAC	569	571	GAC	168;168;168	G;A;C	158;157;155	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4608	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3370	136.4	1	SNP	p	D95N	0	.	.	283	285	GAC	569	571	GAC	168;168;168	G;A;C	158;157;155	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	531	1362	mtrR	633	633	99.68	mtrR.l15.c30.ctg.1	1392	97.6	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	798	798	T	158	T	148	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	646	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1035	62.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4116	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2849	143.5	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1475	1477	ATC	163;160;161	A,G;T;C	149,1;146;149	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4116	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2849	143.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1628	1630	GCA	188;187;184	G;C;A	170;164;164	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4116	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2849	143.5	1	SNP	p	D86N	0	.	.	256	258	GAC	581	583	GAC	154;154;154	G;A;C	144;141;144	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4116	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2849	143.5	1	SNP	p	S87R	0	.	.	259	261	AGT	584	586	AGT	158;159;157	A;G;T	149;150;147	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4116	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2849	143.5	1	SNP	p	S87I	0	.	.	259	261	AGT	584	586	AGT	158;159;157	A;G;T	149;150;147	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4116	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2849	143.5	1	SNP	p	S87W	0	.	.	259	261	AGT	584	586	AGT	158;159;157	A;G;T	149;150;147	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4116	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2849	143.5	1	SNP	p	S88P	0	.	.	262	264	TCC	587	589	TCC	157;156;155	T;C;C	148;149;149	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3766	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2814	133.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1569	1571	GGC	180;178;177	G;G;C	162;160;158	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3274	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2292	141.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1301	1303	GCA	188;189;190	G;C;A	173;176;180	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3274	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2292	141.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1304	1306	ATC	193;193;191	A;T;C	179;181;180	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3274	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2292	141.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1316	1318	GTG	188;189;191	G;T;G	177;176;182	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3274	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2292	141.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1316	1318	GTG	188;189;191	G;T;G	177;176;182	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3274	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2292	141.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1820	1822	ACC	180;178;178	A;C;C	163;163;164	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3274	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2292	141.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1874	1876	GCG	175;178;177	G;C,G;G	155;139,1;153	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3274	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2292	141.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1874	1876	GCG	175;178;177	G;C,G;G	155;139,1;153	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3274	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2292	141.8	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1997	1999	GGT	154;150;150	G;G;T	143;139;138	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3274	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2292	141.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2006	2008	GGC	146;144;142	G;G;C	137;135;129	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3274	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2292	141.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2024	2026	CCG	141;147;150	C,G;C;G	106,8;113;116	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	4956	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3193	154.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1684	1686	CTG	166;165;166	C;T;G	143;142;141	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1780	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1814	97.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	403	405	GGC	122;122;121	G;G;C	114;115;114	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1780	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1814	97.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	585	585	C	119	C	110	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2344	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1420	163.1	0	.	p	.	0	E38K	NONSYN	112	114	GAA	349	351	AAA	225;224;225	A,G;A;A	208,1;209;209	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2344	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1420	163.1	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	868	868	T	193	T	179	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2344	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1420	163.1	1	SNP	p	G120K	0	.	.	358	360	GGT	595	597	GGT	183;182;186	G;G;T	172;172;171	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2344	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1420	163.1	1	SNP	p	A121N	0	.	.	361	363	GCC	598	600	GCC	186;188;187	G;C;C	171;175;173	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2344	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1420	163.1	1	SNP	p	A121D	0	.	.	361	363	GCC	598	600	GCC	186;188;187	G;C;C	171;175;173	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8814	rpoB	4179	4179	99.95	rpoB.l15.c30.ctg.1	4864	180.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	988	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1100	89.5	1	SNP	p	V57M	1	.	.	169	171	ATG	511	513	ATG	195;193;195	A;T;G	187;187;187	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
